Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.

Estes, Lynn; Orenstem, Robert

Estes, Lynn; Orenstem, Robert.

Clin Ther ; 29(4): 759-60; author reply 760-1, 2007 Apr.

Article in En | MEDLINE | ID: mdl-17617300

Subject(s)

Acetamides/therapeutic use; Anti-Bacterial Agents/therapeutic use; Cross Infection/drug therapy; Oxazolidinones/therapeutic use; Pneumonia, Staphylococcal/drug therapy; Staphylococcus aureus/drug effects; Vancomycin/therapeutic use; Acetamides/economics; Anti-Bacterial Agents/economics; Cost-Benefit Analysis; Humans; Linezolid; Methicillin Resistance; Oxazolidinones/economics; Vancomycin/economics

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Staphylococcal / Staphylococcus aureus / Vancomycin / Cross Infection / Oxazolidinones / Acetamides / Anti-Bacterial Agents Type of study: Health_economic_evaluation Limits: Humans Language: En Journal: Clin Ther Year: 2007 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links